Periodontal health and serum, saliva matrix metalloproteinases in patients with mild chronic obstructive pulmonary disease

dc.contributor.authorYildirim, E.
dc.contributor.authorKormi, I.
dc.contributor.authorBasoglu, O. K.
dc.contributor.authorGurgun, A.
dc.contributor.authorKaval, B.
dc.contributor.authorSorsa, T.
dc.contributor.authorBuduneli, N.
dc.date.accessioned2019-10-27T21:52:09Z
dc.date.available2019-10-27T21:52:09Z
dc.date.issued2013
dc.departmentEge Üniversitesien_US
dc.description.abstractYildirimE, Kormi I, Basoglu OK, Gurgun A, Kaval B, Sorsa T, Buduneli N. Periodontal health and serum, saliva matrix metalloproteinases in patients with mild chronic obstructive pulmonary disease. J Periodont Res 2013; 48: 269-275. (C) 2012 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd Background and Objectives The present casecontrol study aimed to evaluate comparatively the salivary and serum levels of matrix metalloproteinases (MMP)-8 and- 13 and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) in patients with mild chronic obstructive pulmonary disease (COPD) and non-COPD controls. Material and Methods Clinical periodontal measurements were recorded before any periodontal intervention in 36 patients with mild COPD and 20 non-COPD controls admitted to Ege University Department of Chest Diseases COPD outpatient clinic (zmir, Turkey). Salivary and serum levels of MMP-8, MMP-13, and TIMP-1 were determined by immunofluorometric assay (IFMA) and enzyme-linked immunosorbent assay (ELISA). Data were analyzed with non-parametric statistical tests. Results Patients with COPD were significantly older than the control group (p<0.05). The COPD group showed significantly higher serum levels of MMP-8 IFMA, MMP-8/TIMP-1 IFMA than the control group (p<0.005). By ELISA, serum MMP-8, MMP-8/TIMP-1, TIMP-1, and MMP-13 levels were similar in both groups (p>0.05). Salivary MMP-8, MMP-13, and TIMP-1 levels were similar in both groups (p>0.05). Conclusions The present findings suggest that immunodetection of MMP-8 is dependent on the selected techniques and even with mild COPD some systemic inflammatory markers such as MMP-8 tend to increase. However, the present clinical periodontal and biochemical findings do not provide support for the previously proposed interaction between COPD and periodontal diseases.en_US
dc.identifier.doi10.1111/jre.12004en_US
dc.identifier.endpage275en_US
dc.identifier.issn0022-3484
dc.identifier.issn1600-0765
dc.identifier.issue3en_US
dc.identifier.pmid22967248en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage269en_US
dc.identifier.urihttps://doi.org/10.1111/jre.12004
dc.identifier.urihttps://hdl.handle.net/11454/47516
dc.identifier.volume48en_US
dc.identifier.wosWOS:000318187400001en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.ispartofJournal of Periodontal Researchen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectchronic obstructive pulmonary diseaseen_US
dc.subjectmatrix metalloproteinasesen_US
dc.subjectperiodontal diseaseen_US
dc.subjectsalivaen_US
dc.subjectserumen_US
dc.subjecttissue inhibitor of matrix metalloproteinases-1en_US
dc.titlePeriodontal health and serum, saliva matrix metalloproteinases in patients with mild chronic obstructive pulmonary diseaseen_US
dc.typeArticleen_US

Dosyalar